CNPOF - Canopy Rivers Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.9380
+0.0107 (+1.15%)
At close: 3:56PM EDT
Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
    9M+
Previous Close0.9273
Open1.0000
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.9269 - 1.0000
52 Week Range0.3715 - 3.0000
Volume30,020
Avg. Volume98,637
Market Cap182.889M
Beta (5Y Monthly)N/A
PE Ratio (TTM)3.61
EPS (TTM)0.2600
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Canopy Rivers Announces Organizational Changes to Streamline Operations
    CNW Group

    Canopy Rivers Announces Organizational Changes to Streamline Operations

    Canopy Rivers Announces Organizational Changes to Streamline Operations

  • Canopy Rivers to Report Fourth Quarter and Fiscal Year 2020 Financial Results
    PR Newswire

    Canopy Rivers to Report Fourth Quarter and Fiscal Year 2020 Financial Results

    Canopy Rivers Inc. (the "Company" or "Canopy Rivers") (TSX: RIV, OTC: CNPOF) will report its financial results for the fourth quarter and fiscal year ended March 31, 2020 before markets open on Friday, May 29, 2020. The Company's audited consolidated financial statements and management's discussion and analysis for the three and twelve months ended March 31, 2020 will be available on the Company's profile on SEDAR at www.sedar.com and on the Company's website at www.canopyrivers.com/investors.

  • Canopy Rivers Targets Cannabis Gummies Market With Investment in Dynaleo
    CNW Group

    Canopy Rivers Targets Cannabis Gummies Market With Investment in Dynaleo

    TORONTO , May 4, 2020 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSX: RIV, OTC: CNPOF) today announced a C$2 million investment in Dynaleo Inc. ("Dynaleo"), an Edmonton -based company focused on white-label manufacturing edible cannabis gummies for the Canadian market. Through this investment in what the Company anticipates may become a leading industrial scale Canadian gummies manufacturer, Canopy Rivers believes it is capitalizing on a significant opportunity in what is currently an underserved and underdeveloped segment of the cannabis market. Once Dynaleo receives the required licencing from Health Canada, it expects to begin operating its 27,000 sq. ft. purpose-built facility with the goal of producing enough gummies to take a sizable bite out of the projected edibles market.

  • Canopy Rivers' Flagship Joint Venture PharmHouse Increases Bank Debt Facility by $10 Million
    CNW Group

    Canopy Rivers' Flagship Joint Venture PharmHouse Increases Bank Debt Facility by $10 Million

    TORONTO , April 16, 2020 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSX: RIV, OTC: CNPOF) today announced that PharmHouse Inc. ("PharmHouse"), its 49%-owned joint venture in Leamington, Ontario , amended its syndicated credit facility ("Credit Facility") with the Bank of Montreal ("BMO"), as the agent and lead lender, and the Canadian Imperial Bank of Commerce and Concentra Bank (together with BMO, the "Lenders"). The amended terms of the Credit Facility (the "Amendment") provides PharmHouse with an additional $10 million of secured debt financing, representing an increase to the Credit Facility that was initially announced in January 2019 .

  • Canopy Rivers Announces Launch of Normal Course Issuer Bid
    CNW Group

    Canopy Rivers Announces Launch of Normal Course Issuer Bid

    TORONTO , March 31, 2020 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.TO) (CNPOF), a venture capital firm specializing in cannabis, announces that the Toronto Stock Exchange ("TSX") has accepted the notice of Canopy Rivers' intention to commence a normal course issuer bid (the "NCIB"). The NCIB reflects management's position that the current share price does not reflect the Company's underlying value and future prospects.

  • Canopy Rivers Portfolio Company Secures C$80.5 Million Debt Financing Arrangement With Canopy Growth
    PR Newswire

    Canopy Rivers Portfolio Company Secures C$80.5 Million Debt Financing Arrangement With Canopy Growth

    Canopy Rivers Inc. ("Canopy Rivers") (TSX: RIV, OTC: CNPOF) portfolio company, TerrAscend Corp. ("TerrAscend") (CSE: TER, OTCQX: TRSSF), today announced that TerrAscend's wholly owned subsidiary, TerrAscend Canada Inc. ("TerrAscend Canada") has entered into an C$80.5 million loan financing arrangement with Canopy Growth Corporation ("Canopy Growth") (TSX: WEED, NYSE: CGC) pursuant to a secured debenture. In connection with the loan, TerrAscend has issued 17,808,975 common share purchase warrants to Canopy Growth.

  • Canopy Rivers' Pharmhouse Joint Venture Receives Milestone Licence Amendment
    PR Newswire

    Canopy Rivers' Pharmhouse Joint Venture Receives Milestone Licence Amendment

    Canopy Rivers Inc. ("Canopy Rivers") (TSX: RIV, OTC: CNPOF) today announced that PharmHouse Inc. ("PharmHouse"), its 49%-owned joint venture in Leamington, Ontario, received a licence amendment from Health Canada allowing for cultivation across its entire greenhouse, which is now fully operational. PharmHouse plans to immediately ramp up production in accordance with its offtake agreements with Canopy Growth Corporation and TerrAscend Canada Inc. PharmHouse has committed 50% of its 2020 output pursuant to these agreements, and currently expects to use the remaining 50% of its capacity for both additional offtake agreements and its own private label brand.

  • Rivers Rundown: Canopy Rivers' Portfolio Companies Expanding Canadian Retail Presence
    PR Newswire

    Rivers Rundown: Canopy Rivers' Portfolio Companies Expanding Canadian Retail Presence

    Canopy Rivers Inc. ("Canopy Rivers") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, portfolio companies have made a series of recent announcements as they aim to seize opportunities in the Canadian retail market. Canopy Rivers also published a new investor presentation following the release of its third quarter financial results. More details on these developments are included below:

  • Canopy Rivers Reports Third Quarter Fiscal Year 2020 Financial Results and Provides Corporate Update
    CNW Group

    Canopy Rivers Reports Third Quarter Fiscal Year 2020 Financial Results and Provides Corporate Update

    Canopy Rivers Reports Third Quarter Fiscal Year 2020 Financial Results and Provides Corporate Update

  • Canopy Rivers Files Early Warning Report in Connection with James E. Wagner Cultivation Investment
    CNW Group

    Canopy Rivers Files Early Warning Report in Connection with James E. Wagner Cultivation Investment

    TORONTO , Feb. 7, 2020 /CNW/ - Canopy Rivers Inc. ("CRI") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, announces that Canopy Rivers Corporation ("Canopy Rivers") subscribed for 2,380,952 units (each a "Unit") of James E. Wagner Cultivation Corporation ("JWC") (TSXV: JWCA, OTCQX: JWCAF) at a price of $0.21 per Unit for total consideration of approximately $500,000 in connection with JWC's non-brokered private placement financing (the "Offering"). Each Unit is comprised of one common share in the capital of JWC (each a "Common Share") and one-half of one Common Share purchase warrant (each full warrant, a "Warrant"). Each Warrant entitles Canopy Rivers to purchase one Common Share at a price of $0.275 per Common Share, at any time on or before February 6, 2023 .

  • Rivers Rundown: Canopy Rivers' CEO Added to NCIA Board, Portfolio Companies Grow North American Footprint
    CNW Group

    Rivers Rundown: Canopy Rivers' CEO Added to NCIA Board, Portfolio Companies Grow North American Footprint

    TORONTO , Feb. 6, 2020 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, and its portfolio companies have made a series of recent announcements that include a board appointment for Canopy Rivers' President & CEO, one brand's retail launch in Canada , and a founder and portfolio company receiving awards for their accomplishments. Other Canopy Rivers portfolio companies hit the milestones required to help further expand and build out their facilities.

  • TerrAscend and Canopy Rivers Amend Terms of Loan to Comply with TSX Policies
    CNW Group

    TerrAscend and Canopy Rivers Amend Terms of Loan to Comply with TSX Policies

    TORONTO , Feb. 5, 2020 /CNW/ - TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend" or the "Company"), the first global cannabis company licensed for sales in the U.S., Canada , and the EU, announced today that the terms of its previously announced US$10 million loan (the "Loan") from Canopy Rivers Corporation ("Canopy Rivers"), a wholly-owned subsidiary of Canopy Rivers Inc. (TSX: RIV, OTC: CNPOF), to TerrAscend Canada Inc. ("TerrAscend Canada"), a wholly-owned subsidiary of TerrAscend, have been amended.

  • Canopy Rivers Amends Terms of Loan to TerrAscend Canada
    CNW Group

    Canopy Rivers Amends Terms of Loan to TerrAscend Canada

    TORONTO , Feb. 5, 2020 /CNW/ - Canopy Rivers Inc. ("CRI") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, announces that as of February 4, 2020 Canopy Rivers Corporation ("Canopy Rivers"), a wholly-owned subsidiary of CRI, has amended the terms of its recent US$10 million loan (the "Loan") to TerrAscend Canada Inc. ("TerrAscend Canada"), a wholly‑owned subsidiary of TerrAscend Corp. ("TerrAscend") (CSE: TER, OTCQX: TRSSF). The Loan, announced October 2, 2019 , included the purchase of 13,243 units, with each unit consisting of: (i) one unsecured convertible debenture of TerrAscend Canada with a principal amount of C$1,000 (the "Debentures"), and (ii) 25.2 common share purchase warrants of TerrAscend allowing for the purchase of common shares of TerrAscend (the "Common Shares") (the "Original Warrants") with an exercise price of C$6.49 .

  • Canopy Rivers to Report Third Quarter Fiscal Year 2020 Financial Results and Host Earnings Call
    CNW Group

    Canopy Rivers to Report Third Quarter Fiscal Year 2020 Financial Results and Host Earnings Call

    Canopy Rivers to Report Third Quarter Fiscal Year 2020 Financial Results and Host Earnings Call

  • Rivers Rundown: Canopy Rivers Portfolio Companies Eyeing Retail Growth, Expanded U.S. Operations
    PR Newswire

    Rivers Rundown: Canopy Rivers Portfolio Companies Eyeing Retail Growth, Expanded U.S. Operations

    Canopy Rivers Inc. ("Canopy Rivers") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, portfolio companies have made a series of recent announcements relating to their plans for the cannabis retail market or U.S. cannabis operations. Two portfolio companies are evaluating opportunities to expand their retail footprint in Canada, while another will remember 2019 as the year it grew its retail presence across the U.S., Canada, and Europe. Another Canopy Rivers portfolio company is taking steps to build out its U.S. operations, as more states look to legalize medical or recreational cannabis. More details on these developments are included below:

  • Canopy Rivers Portfolio Company Receives Approval to Research UV Light Impact on Cannabis Plant
    PR Newswire

    Canopy Rivers Portfolio Company Receives Approval to Research UV Light Impact on Cannabis Plant

    Canopy Rivers Inc. ("Canopy Rivers") (TSX: RIV, OTC: CNPOF) portfolio company BioLumic Ltd. ("BioLumic") has received approval from the New Zealand Ministry of Health to apply its proprietary ultraviolet ("UV") light technology to medical cannabis. While BioLumic's approach has been successful in increasing yields in certain crops, such as strawberries, by up to 60%, this approval marks the first time the company's UV light technology will be used on cannabis. BioLumic hopes that its research will show increased yields in the cannabis plant and help producers meet the rising demand for medical cannabis and cannabis-derived products.

  • Rivers Rundown: Canopy Rivers Portfolio Companies Ending Year on High Note
    PR Newswire

    Rivers Rundown: Canopy Rivers Portfolio Companies Ending Year on High Note

    Canopy Rivers Inc. ("Canopy Rivers") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, portfolio companies made several announcements that demonstrate the portfolio's continued growth heading into 2020. Among others, this includes new features from a business intelligence and analytics software platform, a licensed producer responding to consumer demands for high-THC products with the launch of four new cannabis strains, and a portfolio company expanding its retail footprint. A summary of key developments includes the following:

  • Kevin Durant's Thirty Five Ventures Joins Canopy Rivers' Strategic Advisory Board
    CNW Group

    Kevin Durant's Thirty Five Ventures Joins Canopy Rivers' Strategic Advisory Board

    Kevin Durant's Thirty Five Ventures Joins Canopy Rivers' Strategic Advisory Board

  • PR Newswire

    Rivers Rundown: Canopy Rivers Portfolio Companies Expand Operations, Leadership

    TORONTO, Nov. 21, 2019 /PRNewswire/ - Canopy Rivers Inc. ("Canopy Rivers") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, portfolio companies continued broadening their operations as they aim for success in the growing market. For one company, this meant introducing more tools to help cannabis retailers understand consumers, while another agreed to expand its distribution network by leveraging Canopy Rivers' strategic alliance with Kindred Partners Inc. ("Kindred"). Headset, Inc. ("Headset") launched Retail Market Benchmark for Headset Retailer, its retail data intelligence tool.